Squarepoint’s ENvue Medical Inc FEED Stock Holding History

Squarepoint’s Portfolio FEED Stock Details FEED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13	Closed	-$57K	–	3406
2021 Q3	$57K	Buy	+13	New	+$57.6K	﹤0.01%	2758

Other funds holding FEED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AFS

Amtrust Financial Services New York $336M AUM 16.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Squarepoint's FEED Position: Q4 2021 in Review

Squarepoint sold out of ENvue Medical Inc (FEED) in Q4 2021, closing a stake of 13 shares — an estimated $57K sold.

Squarepoint first reported a position in FEED in Q3 2021 and held it in 1 quarter. The position peaked at $57K in Q3 2021. 19 funds tracked by Wall St. Rank hold FEED as of Q4 2021.

Squarepoint reported no remaining ENvue Medical Inc position as of Q4 2021 after selling out during the quarter.
Squarepoint sold 13 ENvue Medical Inc shares in Q4 2021, an estimated $57K.
Squarepoint first reported a position in ENvue Medical Inc in Q3 2021 and held it in 1 quarter.
Squarepoint's ENvue Medical Inc position peaked at $57K in Q3 2021.
19 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q4 2021.

Based on Squarepoint's 13F filing for Q4 2021, filed 14 Feb 2022.